Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSpirax-Sarco Regulatory News (SPX)

Share Price Information for Spirax-Sarco (SPX)

Share Price is delayed by 15 minutes
Get Live Data
6,810.00    115.00 (1.72%)
Bid:
6,770.00
Ask:
6,775.00
Spread: 5.00 (0.074%)
Market Cap: £5.03b
SPX Live PriceLast checked at - London Stock Exchange

Intraday Spirax-Sarco Share Chart

Interim Management Statement

7 Nov 2008 07:00

RNS Number : 6666H
Spirax-Sarco Engineering PLC
07 November 2008
 



Spirax-Sarco Engineering plc

Charlton House

Cheltenham

Glos. GL53 8ER

News Release

Telephone: 01242 521361

Fax: 01242 581470

www.SpiraxSarcoEngineering.com

Friday 7th November 2008 [embargoed until 7.00 am]

INTERIM MANAGEMENT STATEMENT

Spirax-Sarco Engineering plc, the world leader in the control and efficient use of steam and in peristaltic pumping, issues the following Interim Management Statement based on the four month period to 31st October 2008.

Trading

As expected, we have begun to see some moderation in the pace of growth in demand from our customers, particularly in Continental Europe, although the overall organic sales growth trend in the first half year has broadly continued through October. Despite the Korean Won weakening sharply, currency effects have continued to move in our favour and have added 8% to Group revenues this year, with a larger benefit to operating profit.

Our business is today even more well spread across all geographic regions and across an even wider range of industries and products. We have a large element of replacement sales and the relatively high cost of energy has supported our energy-saving solutions for customers. These factors have historically provided some resilience.

Financial position

We continue to operate with a strong balance sheet. The Group had a net cash balance at 30th June 2008 of £12m, despite having made an initial £11m payment in February for the acquisition of Flexicon. There has been no material change in the financial position of the Group during the period, with net cash balances increasing to £26m at 31st October 2008. The company intends to purchase one million of its own shares to be held in Treasury to meet the requirements of the Group share schemes. The net liability in respect of post-retirement benefits rose to £33m (net of deferred tax) at the half-year and fluctuates in relation to movements in equity and bond markets, which remain volatile. We still expect capital expenditure to be higher than normal this year and in 2009.

Outlook

In our prospects statement in the half-year results announcement made in August, we noted the deteriorating global macro-economic environment, which has been confirmed by more recent GDP and Industrial Production rates and forecasts, and which increases the uncertainty looking forward. However, our business is well spread and generally resilient, and we have a strong balance sheet. We continue to invest for the long term, particularly in developing market areas where economic conditions look more favourable, and are focused on progressively growing our market share. Given continued beneficial exchange rates and no significant deterioration in trading conditions in our markets, we expect to achieve good progress for the year.

Enquiries:

Mark E Vernon, Chief Executive

David Meredith, Director Finance

Tel: 01242 535236

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSBRBDBDGGGGIL
Date   Source Headline
4th Sep 201910:00 amRNSBoard Change
21st Aug 20192:49 pmRNSHolding(s) in Company
14th Aug 20199:02 amRNSHolding(s) in Company
9th Aug 201910:27 amRNSDirector/PDMR Shareholding
8th Aug 20194:26 pmRNSDirector/PDMR Shareholding
7th Aug 20197:00 amRNSHalf-year Report
1st Aug 20195:41 pmRNSChange of Adviser
28th May 20193:08 pmRNSHolding(s) in Company
17th May 20194:16 pmRNSDirector/PDMR Shareholding
16th May 20194:12 pmRNSHolding(s) in Company
15th May 20195:14 pmRNSResult of AGM
15th May 20197:05 amRNSBoard Changes
15th May 20197:00 amRNSAGM Statement - Trading Update
13th May 20192:45 pmRNSCompletion of Acquisition
30th Apr 20199:21 amRNSChange of Director Details
25th Apr 20198:28 amRNSChange of Director Details
11th Apr 20192:36 pmRNSDirector/PDMR Shareholding
15th Mar 201911:25 amRNSAcquisition
7th Mar 20197:00 amRNSFinal Results
1st Mar 20193:04 pmRNSBoard Appointment
18th Feb 20197:00 amRNSExclusive negotiations to acquire Thermocoax
16th Jan 20194:20 pmRNSChange of Director Details
3rd Dec 20187:00 amRNSDisposal
15th Nov 20187:00 amRNSTrading Update
31st Oct 20184:23 pmRNSDirector/PDMR Shareholding
12th Oct 20185:34 pmRNSDirector/PDMR Shareholding
26th Sep 20187:30 amRNSChange of Director Details
20th Sep 201811:16 amRNSHolding(s) in Company
23rd Aug 20184:55 pmRNSHolding(s) in Company
9th Aug 20183:07 pmRNSDirector/PDMR Shareholding
8th Aug 20187:00 amRNSHalf Year Results
31st Jul 201810:22 amRNSHolding(s) in Company
25th Jul 20189:46 amRNSChange of Director Details
20th Jul 201810:00 amRNSExecutive Director Promotion
11th Jun 20184:26 pmRNSHolding(s) in Company
31st May 20188:12 amRNSDirector/PDMR Shareholding
17th May 20189:26 amRNSDirector/PDMR Shareholding
15th May 20184:55 pmRNSResult of AGM
15th May 20187:00 amRNSAGM Statement - Trading Update
25th Apr 20184:27 pmRNSDirector/PDMR Shareholding
6th Apr 20183:32 pmRNSDirector/PDMR Shareholding
4th Apr 20184:17 pmRNSDirector/PDMR Shareholding
29th Mar 20184:24 pmRNSTotal Voting Rights
29th Mar 20184:20 pmRNSDirector/PDMR Shareholding
15th Mar 20187:00 amRNS2017 Preliminary Results
6th Mar 20187:00 amRNSBoard Appointment
14th Feb 20187:00 amRNSBoard Succession Changes
6th Feb 20187:30 amRNSChange of Director Details
20th Dec 20179:07 amRNSChange of Director Details
27th Nov 20174:00 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.